Skip to main content
HairCited

PRP Tedavisi için Androgenetik Alopesi

A

57 çalışmaya (13 meta-analyses, 6 RCTs), toplam 6,423 katılımcıyla dayanmaktadır. 51/57 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dprp\u002Dtherapy\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

PRP therapy is strongly supported by extensive research as a procedure that may help improve hair density in androgenetic alopecia, with 13 meta-analyses confirming positive effects.

  • 57 studies with 13 meta-analyses — one of the most reviewed procedures for hair loss
  • 89% of studies show positive effects on hair density and growth
  • Multiple protocols show benefit: standalone PRP, PRP + microneedling, and PRP + minoxidil
  • No standardized preparation protocol exists, leading to some variability in outcomes

Key Study Findings

Randomized Controlled Trial n=27 12 weeks Single-blind
Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A …
Dose: Monthly for 3 months vs: Untreated side of scalp (split-scalp) Outcome: Global assessment scale change at week 12 Etki: +1.2 GAS; +21 hairs/cm2 treated vs +16 untreated p < 0.001 (GAS); p > 0.05 (bet

Popülasyon: Breast cancer survivors with EIA or pCIA

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: women with androgenetic alopecia (female pattern hair loss)

systematic review
Local Injection versus Topical Microneedling of Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review.
Dose: Autologous platelet-rich plasma (PRP) via syringe injection or topical application with microneedlin vs: Placebo Etki: PRP combined with microneedling appeared superior to direct syringe injection; based on 3 included a None
RCT n=40 12 weeks Open-label
Phase I Clinical Trial: Evaluating the Efficacy, Safety, and Patient Satisfaction of Platelet-Rich Plasma (PRP) …
Dose: None vs: Placebo Etki: PRP: hair count +62.4%, thickness +58.6%; Microneedling: hair count +88.4%, thickness +51.3% p<0.05 (within groups); p>0.05

Key Statistics

144

Çalışmalar

8892

Katılımcılar

Positive

A

Derece

Referenced Papers

Annals of dermatology 2025
International journal of … 2024 39 atıf
Journal of cosmetic … 2024 12 atıf
Journal of cosmetic … 2024 11 atıf
Facial plastic surgery … 2024 8 atıf
Revue medicale suisse 2024 2 atıf
Clinical, cosmetic and … 2023 58 atıf
American journal of … 2023 41 atıf
Clinics in plastic … 2023 1 atıf
Drug design, development … 2022 70 atıf
Faculty reviews 2022 44 atıf
Journal of cosmetic … 2022 35 atıf
The journal of … 2022 22 atıf
Dermatologic surgery : … 2022 15 atıf
American family physician 2022 2 atıf
Facial plastic surgery … 2022
Journal of cosmetic … 2021 23 atıf
Indian dermatology online … 2021 17 atıf
The Senior care … 2021 2 atıf
Expert opinion on … 2020 147 atıf
Facial plastic surgery … 2020 36 atıf
Indian dermatology online … 2020 33 atıf
Dermatologic surgery : … 2020 32 atıf
Journal of drugs … 2020 11 atıf
Dermatologic surgery : … 2019 68 atıf
Aesthetic plastic surgery 2019 45 atıf
Dermatologic therapy 2019 14 atıf
Indian journal of … 2019 10 atıf
Dermatologic clinics 2019 7 atıf
Journal of the … 2018 114 atıf
Facial plastic surgery … 2018 43 atıf
Facial plastic surgery … 2018 42 atıf
Journal of stomatology, … 2017 30 atıf
Stem cell investigation 2017 27 atıf
Dermatologic surgery : … 2014 140 atıf
Expert opinion on … 2014 57 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

hairloss:
3-4 sessions, 4-6 weeks apart

Üst sınır: Not applicable

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
Monthly for 3 months 12 weeks Neutral 27
None -- Neutral --
Autologous platelet-rich plasma (PRP) via syringe injection or topical application with microneedlin -- Positive --
None -- Positive 11
None -- Positive --
None 12 weeks Positive 40
None -- Positive --
None -- Positive --

En iyi alım zamanı: In-clinic procedure; avoid washing hair for 24 hours after treatment

Safety & Side Effects

Bildirilen Yan Etkiler

  • Injection site pain and tenderness
  • Scalp swelling and redness (1-2 days)
  • Headache following treatment
  • Rare: infection at injection site

Bilinen Etkileşimler

  • NSAIDs and aspirin (discontinue 1 week before PRP; affect platelet function)
  • Anticoagulants (may increase bruising; consult physician)
  • Corticosteroid injections (may reduce PRP effectiveness)

Tolere edilebilir üst alım: Not applicable

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does PRP Tedavisi help with Androgenetik Alopesi?
Based on 144 studies with 8,892 participants, there is strong evidence from multiple clinical trials that PRP Tedavisi may support Androgenetik Alopesi management. Our evidence grade is A (Strong Evidence).
How much PRP Tedavisi should I take for Androgenetik Alopesi?
Studies have used various dosages. A commonly studied range is 3-4 sessions, 4-6 weeks apart. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of PRP Tedavisi?
Reported side effects may include Injection site pain and tenderness, Scalp swelling and redness (1-2 days), Headache following treatment, Rare: infection at injection site. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for PRP Tedavisi and Androgenetik Alopesi?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 144 peer-reviewed studies with 8,892 total participants. The overall direction of effect is positive.

Related Evidence

PRP Tedavisi diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.